COVID-19 Testing Details


The COVID-19 RT-PCR assay in use by CQuentia employs selective amplification of nucleic acid via target-specific primers for ORF 1a, a non-structural region that is unique to SARS-CoV-2, and a conserved region in the structural protein envelope E-gene. This dual target approach allows for both specific detection of SARS-CoV-2, and for pan-Sarbecovirus detection of the sarbecovirus subgenus family that includes SARS-CoV-2.

Additionally, CQuentia can result COVID-19 via selective nucleic acid amplification and probing of specific SARS-CoV-2 target sequences found in the ORF1 ab, Nucleocapsid (N) Protein, and Spike (S) Protein genes. These regions are known to have higher specificity and exhibit a lower risk of mutation.

Price: $250.00

Regulatory Information